Leukemia Posts - Page 37 of 71 on Medivizor
Navigation Menu

Leukemia Posts on Medivizor

Tiredness in children and teenagers with leukemia/lymphoma and stem cell transplants

Tiredness in children and teenagers with leukemia/lymphoma and stem cell transplants

Posted by on Dec 15, 2018 in Leukemia | 0 comments

In a nutshell This study aimed to identify risk factors of tiredness in children treated for leukemia and lymphoma or who received a stem cell transplant. Researchers found that older age and active treatment were risk factors for developing severe tiredness in these patients. Some background Cancer treatment leads to severe tiredness (fatigue) over...

Read More

Is MRD related to treatment and survival in patients with chronic lymphocytic leukemia?

Is MRD related to treatment and survival in patients with chronic lymphocytic leukemia?

Posted by on Dec 12, 2018 in Leukemia | 0 comments

In a nutshell This study wanted to compare the effectiveness of chlorambucil (Leukeran) plus either obinutuzumab (Gazyva) or rituximab (Rituxan) in the treatment of frail patients with chronic lymphocytic leukemia (CLL). Researchers found that chlorambucil with obinutuzumab (G-Clb) was more effective than with rituximab (R-Clb) in these...

Read More

Survival from transplant of donor bone marrow versus donor blood sample in leukemia treatment

Posted by on Dec 12, 2018 in Leukemia | 0 comments

In a nutshell This study compared the safety and effectiveness of donor peripheral blood (PB) with bone marrow (BM) transplant in the treatment of leukemia. Researchers found that bone marrow transplants are safer and more effective in the treatment of leukemia. Some background Leukemia is a cancer of the bone marrow. It may lead to abnormal immune...

Read More

Searching for patients with acute lymphoblastic leukemia to test new treatment combination

Posted by on Dec 11, 2018 in Leukemia | 0 comments

In a nutshell This trial is comparing the effectiveness of ponatinib (Iclusig) with imatinib (Gleevec) together with low-dose standard chemotherapy for the treatment of patients with acute lymphoblastic leukemia (ALL). The main outcome to be measured is minimal residual disease (low levels of cancer markers in the blood). This study will...

Read More

Evaluating the use of ibrutinib with bendamustine and rituximab treatment in unresponsive chronic lymphocytic leukemia

Evaluating the use of ibrutinib with bendamustine and rituximab treatment in unresponsive chronic lymphocytic leukemia

Posted by on Dec 8, 2018 in Leukemia | 0 comments

In a nutshell This study looked at the safety and effectiveness of ibrutinib (Imbruvica) added to bendamustine (Treanda) and rituximab (Rituxan) in the treatment of unresponsive chronic lymphocytic leukemia. Researchers found that this treatment improved survival in these patients. Some background Chronic lymphocytic leukemia (CLL) is a...

Read More

The effect of ibrutinib on white blood cell count in CLL

Posted by on Dec 6, 2018 in Leukemia | 0 comments

In a nutshell This study wanted to look at the effect of ibrutinib (Imbruvica) on white cell count (immune cells) in patients with chronic lymphocytic leukemia. Researchers found that increases in white cell count during ibrutinib treatment were normal and did not indicate poor outcomes in these patients. Some background Chronic lymphocytic leukemia...

Read More

Evaluating the safety and effectiveness of ponatinib for CML

Evaluating the safety and effectiveness of ponatinib for CML

Posted by on Dec 6, 2018 in Leukemia | 0 comments

In a nutshell The study looked at the safety and effectiveness of ponatinib (Iclusig) in the treatment of chronic myeloid leukemia (CML). Researchers found that ponatinib was safe and effective in previously treated patients with CML. Some background Chronic myeloid leukemia is a type of cancer of the bone marrow. This can lead to abnormal immune...

Read More

Do ACE inhibitors help with anthracycline-induced cardiotoxicity in leukemia and lymphoma?

Posted by on Dec 6, 2018 in Leukemia | 0 comments

In a nutshell This study aimed to investigate if enalapril influences anthracycline-induced cardiotoxicity in children with leukemia and lymphoma. This study concluded that enalapril has a role in reducing anthracycline-induced cardiotoxicity in these patients. Some background Anthracyclines are a class of chemotherapy drugs that can be used for...

Read More

The safety and effectiveness of bosutinib in patients with chronic myeloid leukemia

The safety and effectiveness of bosutinib in patients with chronic myeloid leukemia

Posted by on Nov 30, 2018 in Leukemia | 0 comments

In a nutshell This study looked at the safety and effectiveness of bosutinib (Bosulif) in the treatment of chronic myeloid leukemia (CML). Researchers found that bosutinib was effective in patients who have failed other similar drug treatments. Some background Chronic myeloid leukemia (CML) is a cancer of the bone marrow. This can lead to abnormal...

Read More